ID: MRFR/MED/1681-HCR | February 2021 | Region: Global | 100 pages
Global Brain Monitoring Devices Market is expected to grow at a CAGR of 6% during the forecast period 2019 to 2025.
The ability to quantify reliable alterations in the physical and biochemical environment after a brain injury is of great value in the prevention, medication, and understanding of secondary injuries.
Moreover, according to CDC, traumatic brain injury is a leading cause of \mortality, responsible for 2.8 million accidents and emergency department visits annually in the US and about 1 million in the UK. It is one of the most common causes of mortality in people aged under 25, and its incidence is high in adults and infants as well.
Intracranial pressure (ICP) monitoring, as stand-alone value or study of a dynamic trend, has become an important diagnostic tool in the diagnosis and management of multiple neurological conditions. Efforts have been made to measure ICP non-invasively, but this process is not a clinical reality yet. There is differing evidence that monitoring of ICP is associated with a better outcome, and further RCTs based on management protocol are warranted.
Moreover, as per the statistics of WHO in 2017, around 50 million people all over the world were affected with epilepsy. Furthermore, as stated by the Epilepsy Society, epilepsy is commonly diagnosed in people over 65, and 5.2% of 50 million are people aged above 60
|Market Size||2027: Significant Value|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Application, Type, End-User|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Advanced Brain Monitoring,Philips Healthcare,GE Healthcare,Siemens Healthineers,Nihon Kohden Corporation,Medtronic,Drägerwerk AG & Co. KGaA,Neurosoft,Integra LifeSciences Corporation,Olympus Corporation|
|Key Market Opportunities||
|Key Market Drivers||High costs associated with the treatment and monitoring|
Frequently Asked Questions (FAQ) :
Transcranial doppler is the largest segment in the global brain monitoring market.
Growing prevalence of neurological disorders, rising adoption rate of remote monitoring devices, and increasing healthcare expenditure are the major tailwinds pushing the growth of the global brain monitoring market.
North America holds the largest share in the global brain monitoring market, followed by Europe and the Asia Pacific, respectively.
Koninklijke Philips N.V. (The Netherlands), GE Healthcare (UK), Welch Allyn (US), Spacelabs Healthcare (US), Nihon Kohden (Japan), CompuMed, Inc. (US), CardioNet (US), Schiller (Switzerland), Medtronic plc (Ireland), Natus Medical Inc. (US), CAS Medical Systems, Inc. (US), and Electrical Geodesics Incorporated (US), are some of the major players operating in the brain monitoring market.
Strategic initiatives such as mergers & acquisitions, collaborations, expansion, and technology/ product launch are some of the growth strategies that players operating in the global brain monitoring market adopt to gain a larger competitive advantage.